XML 65 R7.htm IDEA: XBRL DOCUMENT v3.23.1
Statements of Cash Flows (Unaudited) - USD ($)
3 Months Ended 5 Months Ended 12 Months Ended
Mar. 31, 2023
Mar. 31, 2022
Dec. 31, 2021
Dec. 31, 2022
Cash flows from operating activities:        
Net Loss $ (16,762) $ (59,400) $ (307,949) $ 53,884
Adjustments to reconcile net loss to net cash used in operating activities:        
Interest income from Trust Account (210,161) (11,705) (1,349) (1,348,596)
Changes in operating assets and liabilities:        
Accounts payable     11,579
Prepaid expenses (21,251) (279,179) (7,505) (135,550)
Accrued expenses (19,959) (41,239) 43,871 642,324
Other payables 30,000 30,000 20,000 120,000
Net cash used in operating activities (238,133) (361,523) (241,353) (667,938)
Cash flows from investing activities:        
Investment of Cash in Trust Account (426,483) (116,725,000)
Net cash used in investing activities (426,483) (116,725,000)
Cash flows from financing activities:        
Proceeds from extension loan 255,889
Extension loan received from receivables 170,594
Proceeds from working capital loan 209,682
Proceeds from issuance of Class B ordinary shares to Sponsor     25,000  
Payment of Offering Costs     (303,020)  
Proceeds from the sale of Units, net of underwriting discount paid     112,725,000  
Proceeds from sale of Private Placement Units     5,280,750  
Payment of promissory note to related party     (22,197)  
Payment of Accrued expenses     (23,453)  
Net cash provided by financing activities 636,165 117,682,080
Net change in cash (28,451) (361,523) 715,727 (667,938)
Cash at the beginning of the period 47,789 715,727 715,727
Cash at the end of the period 19,338 354,204 715,727 47,789
Supplemental disclosure of non-cash financing activities:        
Deferred underwriting fee payable 4,025,000 4,025,000 4,025,000 4,025,000
Value of Class A ordinary shares subject to redemption 20,172,591 116,725,000 $ 116,725,000 19,535,946
Extension loan receivable       $ 170,594
Re-measurement for ordinary share to redemption amount $ 210,161